Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment

NCT01678482 | Completed

• 1 other identifier: C1
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This is a clinical research study to determine the ability of the Clear device to treat mild to moderate inflammatory acne, and to determine if the average person is able to use the device properly according to the labeling as describe in the operator manual. The study involve treatments twice a week over 4 weeks total of 8 treatment sessions, in which the subjects will be treating themselves with the Clear device, and 2 follow-up visits to evaluate the results. The clinical result will be assessed by the investigator for improvement in the acne condition. Treatment will be performed on the face of subjects enrolled and who meet the inclusion criteria.

Conditions

Monitor Acne Lessions Count Reduction as Result of Usinfg the Device

Keywords

Acne, LED, blue light

Outcome Measures

Primary Outcomes (1)

• Acne lession count

  acne count post treatment compared to based line count

  3 months post treatment

Study Arms (1)

lession count reduction post treatment

EXPERIMENTAL

* A total of 50 subjects were included. * The majority are female (62 %) * At baseline the average number of lesions was 20.5±7.1, ranging from 6 to 36 lesions. * All subjects demonstrated a reduction in lesion count. * The average improvement after one month was 56.7%±8.9%, and remained similar also after 3 months 57.7%±9.4%. * The percent of responders (with at least 40% of reduction) was 94% after 1 month and 96% after 3 months * The Percent of responders is similar for males \& females and similar for cheeks \& front.

Device: light based device for treatment of acne

Interventions

light based device for treatment of acne DEVICE

lession count reduction post treatment

Eligibility Criteria

• Age: 21 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Presence of mild to moderate acne.
• Skin Type I to VI (Fitzpatrick).
• Males or females who are 21-65 years old.
• Willingness to follow the treatment schedule, post-treatment care and have photographs taken.

You may not qualify if:

• Pacemaker or internal defibrillator.
• Permanent implant in the treated area, such as metal plates and screws or silicon, unless deep enough in the bone.
• Skin areas that have been injected with Botox/ Hyaluronic acid /collagen/fat injections or other augmentation methods with bio-material during last 6 months.
• Current or history of skin cancer, or any other type of cancer, or pre-malignant moles.
• Current severe medical conditions, such as heart and lung disorders.
• Pregnant or breastfeeding.
• Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
• History of diseases stimulated by heat, such as recurrent Herpes Simplex (cold sores) in the treatment area, unless treated by following a preventive regime.
• Poorly controlled endocrine disorders, such as diabetes or thyroid disorders.
• Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and rash and rosacea.
• History of skin disorders, keloids (excessive scarring), abnormal wound healing, as well as very dry and fragile skin.
• History of bleeding disorders, or use of anticoagulants in the last 10 days.
• Any facial surgery performed within 12 months prior to treatment.
• Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last 3 months.
• Received treatment with light, laser, radiofrequency (RF), or other devices in the treated area within 6 months.

Sponsors & Collaborators

• Home Skinovations Ltd.: lead

Study Sites (1)

SpaMedica

Toronto, Ontario, M5R3N8, Canada

Location

MeSH Terms

Conditions

Acne Vulgaris

Condition Hierarchy (Ancestors)

Acneiform Eruptions; Skin Diseases; Skin and Connective Tissue Diseases; Sebaceous Gland Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 31, 2012
• First Posted: September 5, 2012
• Study Start: November 1, 2011
• Primary Completion: April 1, 2012
• Study Completion: April 1, 2012
• Last Updated: September 5, 2012

Record last verified: 2012-08

Locations

CA (1)